Article Information
History
- August 22, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Haiying Zhang¶,
- Yuyuan Jia¶,
- Ying Ji,
- Xu Cong,
- Yan Liu,
- Ruifeng Yang,
- Xiangsha Kong,
- Yijun Shi,
- Ling Zhu,
- Zhenyu Wang,
- Wei Wang,
- Ran Fei,
- Feng Liu,
- Fengmin Lu,
- Hongsong Chen* and
- Huiying Rao*
- Peking University People’s Hospital, Peking University Hepatology Institute, National Clinical Research Center for Infectious Disease, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing International Cooperation Base for Science and Technology on NAFLD Diagnosis, Beijing, China
- ↵*Corresponding author E-mail: raohuiying{at}pkuph.edu.cn(HR); chenhongsong{at}pkuph.edu.cn(HC)
↵¶ These authors contributed equally to this work.
Posted August 22, 2021.
Studies on the level of neutralizing antibodies produced by inactivated COVID-19 vaccines in the real world
